|
ATE243198T1
(de)
*
|
1997-01-06 |
2003-07-15 |
Cerus Corp |
Verbindungen mit leicht spaltbaren bindungen zur inaktivierung von pathogenen
|
|
DE69826521T2
(de)
*
|
1998-01-06 |
2005-09-29 |
Cerus Corp., Concord |
Verfahren zum quenchen von pathogen-inaktivatoren in biologischen materialien
|
|
US6281225B1
(en)
|
1998-06-11 |
2001-08-28 |
Cerus Corporation |
Inhibiting proliferation of arterial smooth muscle cells
|
|
US7049110B2
(en)
|
1998-07-21 |
2006-05-23 |
Gambro, Inc. |
Inactivation of West Nile virus and malaria using photosensitizers
|
|
US7498156B2
(en)
|
1998-07-21 |
2009-03-03 |
Caridianbct Biotechnologies, Llc |
Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
|
|
US6403359B1
(en)
|
1998-09-25 |
2002-06-11 |
V. I. TECHNOLOGIES, Inc. |
Solid phase quenching systems
|
|
US6150109A
(en)
|
1999-01-25 |
2000-11-21 |
V. I. TECHNOLOGIES, Inc. |
Lipophilic quenching of viral inactivating agents
|
|
US7094378B1
(en)
|
2000-06-15 |
2006-08-22 |
Gambro, Inc. |
Method and apparatus for inactivation of biological contaminants using photosensitizers
|
|
US7220747B2
(en)
|
1999-07-20 |
2007-05-22 |
Gambro, Inc. |
Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
|
|
CN1436083A
(zh)
*
|
2000-05-31 |
2003-08-13 |
塞鲁斯公司 |
制备病原体灭活的低免疫原性红细胞溶液
|
|
US9044523B2
(en)
|
2000-06-15 |
2015-06-02 |
Terumo Bct, Inc. |
Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
|
|
DE10051628B4
(de)
*
|
2000-10-18 |
2007-06-06 |
Fresenius Hemocare Beteiligungs Gmbh |
Einzelsträngiges Oligonukleotid und dessen Verwendung
|
|
US20030113704A1
(en)
*
|
2000-12-21 |
2003-06-19 |
Cerus Corporation |
Methods for inactivation of pathogens in biological materials
|
|
KR101173871B1
(ko)
*
|
2003-02-06 |
2012-08-16 |
앤저 테라퓨틱스 인코퍼레이티드 |
변형된 독립생존 미생물, 백신 조성물 및 그것의 사용방법
|
|
US7695725B2
(en)
|
2003-02-06 |
2010-04-13 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
|
ATE552843T1
(de)
|
2003-02-06 |
2012-04-15 |
Aduro Biotech |
Listerien deren eindringen in nicht-phagozytische zellen abgeschwächt ist, impfstoffe, die diese listerien enthalten und deren verwendungen
|
|
US7842289B2
(en)
|
2003-12-24 |
2010-11-30 |
Aduro Biotech |
Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
|
|
JP5346468B2
(ja)
|
2004-10-29 |
2013-11-20 |
シーラス コーポレイション |
赤血球不活性化プロセスのための改善されたクエンチング方法
|
|
KR101896430B1
(ko)
|
2008-04-09 |
2018-09-10 |
세루스 코포레이션 |
적혈구 병원체 불활성화를 위한 개선된 퀀칭 방법
|
|
US9353122B2
(en)
|
2013-02-15 |
2016-05-31 |
Kala Pharmaceuticals, Inc. |
Therapeutic compounds and uses thereof
|
|
US9353123B2
(en)
|
2013-02-20 |
2016-05-31 |
Kala Pharmaceuticals, Inc. |
Therapeutic compounds and uses thereof
|
|
US9688688B2
(en)
|
2013-02-20 |
2017-06-27 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
|
|
KR20160099084A
(ko)
|
2013-11-01 |
2016-08-19 |
칼라 파마슈티컬스, 인크. |
치료 화합물의 결정질 형태 및 그의 용도
|
|
US9890173B2
(en)
|
2013-11-01 |
2018-02-13 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
CN104788373A
(zh)
*
|
2015-05-06 |
2015-07-22 |
武汉大学 |
化合物s-303盐酸盐的合成方法
|
|
CN122182613A
(zh)
|
2015-06-26 |
2026-06-12 |
塞鲁斯公司 |
冷沉淀物组合物及其制备方法
|
|
CN104991033A
(zh)
*
|
2015-08-05 |
2015-10-21 |
上海海虹实业(集团)巢湖今辰药业有限公司 |
一种采用一测多评法测定川芎挥发油成分的方法
|
|
US10799533B2
(en)
|
2015-10-23 |
2020-10-13 |
Cerus Corporation |
Plasma compositions and methods of use thereof
|
|
WO2018048750A1
(en)
|
2016-09-08 |
2018-03-15 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
EP3509421A4
(en)
|
2016-09-08 |
2020-05-20 |
Kala Pharmaceuticals, Inc. |
CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF
|
|
US10253036B2
(en)
|
2016-09-08 |
2019-04-09 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
AU2017382449B2
(en)
*
|
2016-12-23 |
2024-10-24 |
Cerus Corporation |
Systems and methods for testing and screening using compound bound substrates
|
|
EP4606379A3
(en)
|
2017-03-03 |
2025-11-19 |
Cerus Corporation |
Kits and methods for preparing pathogen-inactivated platelet compositions
|
|
JP7311518B2
(ja)
|
2017-12-29 |
2023-07-19 |
シーラス コーポレイション |
生物学的流体を処理するためのシステムおよび方法
|
|
WO2020263745A1
(en)
|
2019-06-22 |
2020-12-30 |
Cerus Corporation |
Systems and methods for implementing treatment of biological fluids
|
|
CN114173842B
(zh)
|
2019-06-22 |
2026-07-14 |
塞鲁斯公司 |
生物流体处理系统
|
|
JP7645203B2
(ja)
|
2019-06-28 |
2025-03-13 |
シーラス コーポレイション |
生物学的流体処理デバイスを実装するためのシステム及び方法
|